Global teleradiology provider Everlight Radiology are pleased to announce that Rob Anderson has been appointed by its Board as Global CEO, starting in January 2023.
Rob replaces Alexander van der Laan, who will step down after 10 years as Global CEO into a non-executive director and investor position.
van der Laan: “As the Founders did for me over 10 years ago, the time is right for me to create space for others by moving into a supporting role. The Board and I have made this decision carefully and together. I am very proud of Everlight. In announcing this natural change and refresh at the top I see only positive glow around my team, our doctors and the future prospects of Everlight.”
Anderson, based in the UK, brings with him a wealth of experience in complex public, private and PE-backed highly regulated healthcare settings, most recently as CEO of Aspen Healthcare.
Anderson will work with the existing management team and Medical Leadership Council to continue to deliver on Everlight’s mission, strategy and plan - enabling better patient care and serving as a vital lifeline of radiology reporting capacity to public healthcare globally.
Anderson says, “I am delighted to be joining the team at Everlight Radiology as Group CEO.
Everlight is at the leading edge of global teleradiology, driven by an exceptional management team, dedicated staff and world-class Radiologists. Together, we have an enormous opportunity to ensure that our innovative and intelligent solutions make an ever-increasing contribution to the constantly evolving global healthcare landscape.
I very much look forward to helping define and lead the next steps of this exciting journey, building upon the success of Everlight to date and continuing to support our clients around the clock (and around the world).”
This global search, appointment and orderly transition comes a year after Livingbridge invested in Everlight Radiology, on the basis of the strength of its strategy and market position as the leading global teleradiology provider.
The leadership team, which includes the Medical Leadership Council, a global Clinical Directorate chaired by Dr Dan Rose and the existing Global Executive Team, including Daniel Sourial, CEO UK&I, and Wayne Hartmann, Group COO, remain vital to assisting Anderson gets the best start. Together they will ensure the continuity of strategy and culture of care. Alexander will work alongside Board member Dr Charles Lott, also a founding member of Everlight.